AU Patent

AU2015321462B2 — Humanized anti-hepcidin antibodies and uses thereof

Assigned to Intrinsic LifeSciences LLC · Expires 2020-04-30 · 6y expired

What this patent protects

The present application relates to humanized antibodies that specifically bind to hepcidin and methods of using the humanized antibodies. Another aspect relates to humanized antibodies which bind hepcidin and regulate iron homeostasis. Another aspect relates to the use of humaniz…

USPTO Abstract

The present application relates to humanized antibodies that specifically bind to hepcidin and methods of using the humanized antibodies. Another aspect relates to humanized antibodies which bind hepcidin and regulate iron homeostasis. Another aspect relates to the use of humanized antibodies which bind hepcidin for the treatment of a disease or condition associated with hepcidin.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015321462B2
Jurisdiction
AU
Classification
—
Expires
2020-04-30
Drug substance claim
No
Drug product claim
No
Assignee
Intrinsic LifeSciences LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.